Effect of treatment with budesonide CIR capsules and prednisolone on bone density, bone metabolism and osteoporosis in patients with Crohn's disease, measured using dual energy X-ray absorptiometry (MATRIX).
Study identifier:08-3039
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
Effect of treatment with budesonide CIR capsules and prednisolone on bone density, bone metabolism and osteoporosis in patients with Crohn's disease, measured using dual energy X-ray absorptiometry (MATRIX).
Medical condition
Crohn's disease
Phase
Phase 3
Healthy volunteers
-
Study drug
-
Sex
-
Actual Enrollment
-
Study type
Interventional
Age
-
Date
Study Start Date: 01 Jul 1996
Primary Completion Date: -
Study Completion Date: -
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Nov 2013 by AstraZeneca
Sponsors
AstraZeneca
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|
